These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17160908)

  • 1. Early and intensive treatment: Glycaemic control in type 2 diabetes.
    Bailey CJ
    Diab Vasc Dis Res; 2006 Dec; 3(3):145-6. PubMed ID: 17160908
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycaemic control in diabetes.
    Herman W
    Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intensive blood glucose reduction: yes or no?].
    Bischoff A
    MMW Fortschr Med; 2015 Mar; 157(4):18-9. PubMed ID: 25743962
    [No Abstract]   [Full Text] [Related]  

  • 4. Defining the role of basal and prandial insulin for optimal glycemic control.
    Horton ES
    J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S21-7. PubMed ID: 19179213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of hyperglycaemia in type 2 diabetes: a patient-centered approach].
    Scheen AJ; Mathieu C
    Rev Med Liege; 2012 Dec; 67(12):623-31. PubMed ID: 23342872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbA1c targets in type 2 diabetes: guidelines and evidence.
    Drug Ther Bull; 2013 Apr; 51(4):42-5. PubMed ID: 23557845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 8. Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes.
    Matthews DR; Tsapas A
    Diab Vasc Dis Res; 2008 Sep; 5(3):216-8. PubMed ID: 18777497
    [No Abstract]   [Full Text] [Related]  

  • 9. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?
    Zenari L; Marangoni A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():17-25. PubMed ID: 24034516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing hyperglycaemia.
    Curtis S
    Br J Gen Pract; 2008 Oct; 58(555):729; authore reply 729-30. PubMed ID: 18826786
    [No Abstract]   [Full Text] [Related]  

  • 11. Type 2 diabetes - controlling hyperglycaemia with early insulin use.
    MacIsaac R; Cheung A; Jerums G
    Aust Fam Physician; 2010 Aug; 39(8):565-9. PubMed ID: 20877750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines].
    Adler AI; Shaw EJ; Stokes T; Ruiz F
    Praxis (Bern 1994); 2009 Oct; 98(20):1161-3. PubMed ID: 19809980
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience.
    Trevisan R; Bonizzoni E; Bosi E; Ceriello A; Cucinotta D; Giorgino F; Tiengo A; Scavini M
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):169-70. PubMed ID: 26803592
    [No Abstract]   [Full Text] [Related]  

  • 14. How can we monitor glycaemic variability in the clinical setting?
    Inchiostro S; Candido R; Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on the AACE/ACE statement on glycemic control for patients with type 2 diabetes mellitus.
    Eledrisi M
    Endocr Pract; 2010; 16(1):130-1; author reply 131-2. PubMed ID: 20146995
    [No Abstract]   [Full Text] [Related]  

  • 16. [A critical appraisal of the European guidelines on diabetes, pre-diabetes and cardiovascular diseases].
    Miccoli R
    G Ital Cardiol (Rome); 2014 Jun; 15(6):350-4. PubMed ID: 25072420
    [No Abstract]   [Full Text] [Related]  

  • 17. Which patients should be evaluated for blood glucose variability?
    Candido R
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():9-12. PubMed ID: 24034514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic control and cardiovascular disease: is there a light at the end of the tunnel?
    Knobler H; Chajek-Shaul T
    QJM; 2017 Jul; 110(7):421-423. PubMed ID: 27521580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of glycosylated serum protein and glycosylated hemoglobin in patients with diabetes mellitus type 2 at various stages of metabolic compensation].
    Plechanow J; Bartosiewicz W; Szczepanik Z
    Pol Arch Med Wewn; 1987 Sep; 78(3):149-53. PubMed ID: 3271294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.